ClinicalTrials.Veeva

Menu

3D Analysis of Soft Tissue Healing After Immediate Implant Placement Using PRF Vs HAM

A

Ain Shams University

Status

Active, not recruiting

Conditions

Badly Broken Down Vital Teeth
Badly Broken Maxillary Premolars Indicated for Extraction

Treatments

Procedure: Human amniotic membrane
Procedure: No grafting
Procedure: PRF

Study type

Interventional

Funder types

Other

Identifiers

NCT06834802
3D soft tissue assessment

Details and patient eligibility

About

Statement of the problem: Soft tissue healing following immediate implant placement is one of the major factors that affect implant restoration, function & success.

Aim: The aim of this study is to compare the effect of using HAM (Human amniotic membrane) and platelet rich fibrin (PRF) in soft tissue healing with immediate implant placement in the molar region.

Full description

Aim: The aim of this study is to compare the effect of using HAM (Human amniotic membrane) and platelet rich fibrin (PRF) in soft tissue healing with immediate implant placement in the molar region.

Materials and Methods: This parallel arm, randomized controlled clinical trial will involve systemically free patients with remaining roots or badly decayed teeth in molar sites region requiring implant placement. They will be randomly allocated to three equal groups. Group A (test group, n=12) will receive immediate implants (grafting with PRF), group B (test group, n=12) will receive immediate implants (grafting with HAM) and group c (test group, n=12) will receive immediate implants (no grafting). After implant placement, soft tissue healing (1ry outcome) and postoperative pain (2nd outcome) will be assessed. The parameters will be assessed at baseline, every day for the first week, day after day second week, once in third and fourth week. Postoperative pain and swelling will be recorded daily by the patient for the 1st two weeks post surgically. Postoperative medication will be prescribed to the patient and postoperative instructions will be explained in detail. Follow-up will be performed to assess the parameters and to ensure performing proper oral hygiene. Data collected will be tabulated and statistically analyzed.

Enrollment

36 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Patients at least 18 years old, with non-restorable first and second molars.
  2. Minimum remaining alveolar height of four to six millimeters distance from the apex of the socket to the floor of maxillary sinus for maxillary teeth and minimum remaining alveolar height of six millimeters distance from the apex of the socket to the inferior alveolar nerve for mandibular teeth.
  3. Minimum alveolar Bucco-palatal dimension of 7 mm.

Exclusion criteria

  1. Patients with known systemic diseases which can affect normal bone formation or blood coagulation.
  2. Patients who are smokers.
  3. Presence of signs of active infection or pus formation.
  4. Absence or loss of buccal wall prior to implant placement.
  5. Bad oral hygiene

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

36 participants in 3 patient groups

Grafting with PRF
Active Comparator group
Description:
immediate implant will be placed and PRF membrane will be placed into the soft tissue. The PRF plug will be maintained in place with approximating sutures using 5-0 resorbable suture material.
Treatment:
Procedure: PRF
Grafting using Human amniotic membrane (HAM)
Active Comparator group
Description:
immediate implant placement will be done and The HAM plug will be placed into the soft tissue.
Treatment:
Procedure: Human amniotic membrane
No Grafting
Active Comparator group
Description:
Immediate implant placement will be done and with no soft tissue grafting
Treatment:
Procedure: No grafting

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems